AF drug cleared for use in final NICE guidance

Atrial fibrillation (AF) drug dronedarone has been recommended by NICE for limited second-line use in final guidance issued this week.

The institute originally rejected the drug in draft guidance published last year, arguing that it was not cost effective.

It overturned this decision in March after criticism from the Atrial Fibrillation Association and hundreds of healthcare professionals and MPs.

NICE said it had decided to recommend use of dronedarone because, although it is more expensive, it is associated with fewer adverse effects than other antiarrythmic drugs.

The guidance recommends that dronedarone should only be used in patients whose AF cannot be controlled by first-line therapy with beta blockers.

It also recommended that it should be limited to patients who also meet one of the following risk factors:

  • diabetes
  • hypertension requiring treatment with at least two different drug classes
  • previous systemic embolism, stroke or TIA
  • left atrial diameter greater than 50mm
  • left ventricular ejection fraction of less than 40%
  • aged 70 years or older without NYHA class III or IV heart failure

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

LMCs demand renegotiation of COVID-19 enhanced service deal

LMCs demand renegotiation of COVID-19 enhanced service deal

LMCs have called for a renegotiation of funding for the COVID-19 vaccination enhanced...

LMCs demand ballot of profession on PCN DES ahead of next contract talks

LMCs demand ballot of profession on PCN DES ahead of next contract talks

LMCs have demanded a ballot of GPs on the primary care network (PCN) DES before BMA...

Lack of support left locums at physical and financial risk in pandemic, say LMCs

Lack of support left locums at physical and financial risk in pandemic, say LMCs

Locum GPs have faced significant physical and financial risk because of a lack of...

LMCs demand NHS England apology over ‘abhorrent' claims about general practice

LMCs demand NHS England apology over ‘abhorrent' claims about general practice

LMCs have called on NHS England to apologise for ‘abhorrent and insulting’ suggestions...

CCGs to be stripped of commissioning role under reforms backed by NHS England

CCGs to be stripped of commissioning role under reforms backed by NHS England

CCGs could be stripped of their commissioning role under plans set out by NHS England,...

Shielding advice updated to reflect return to tiered system on 2 December

Shielding advice updated to reflect return to tiered system on 2 December

The government has updated its guidance for patients on the shielding list to reflect...